Journal List > Urogenit Tract Infect > v.12(3) > 1084215

Jung, Jeong, Baek, and Ryu: Risk Factors of Sepsis and Factors Influencing the Decision to Perform Emergency Drainage in Obstructive Acute Pyelonephritis Secondary to Urinary Calculi

Abstract

Purpose:

To investigate the risk factors for sepsis and analyze the criteria for emergency drainage in patients with obstructive acute pyelonephritis (APN) secondary to urinary calculi.

Materials and Methods:

We included 64 patients with obstructive APN secondary to urinary calculi. Patients were divided into two groups: the sepsis and non-sepsis groups. Independent risk factors for sepsis were also identified. Forty-three patients in the sepsis group were further divided into two subgroups: those who underwent emergency drainage and those who did not. A retrospective analysis was performed.

Results:

Of the 64 patients, 43 showed signs of sepsis. There was a lower lymphocyte count and lymphocyte percentage, as well as a higher C-reactive protein level and neutrophil-to-lymphocyte ratio (NLR) in the sepsis group compared with the non-sepsis group. Increased sepsis showed a statistically significant association with increased Charlson comorbidity index (CCI). Four out of 21 patients in the non-sepsis group underwent emergency drainage compared with 26 out of 43 patients in the sepsis group. Independent variables for sepsis in a multivariate logistic regression analysis showed positive blood culture, high NLR, and increased CCI score. Among sepsis patients, the likelihood of performing emergency drainage increased with higher creatinine, positive urine culture, and higher CCI score.

Conclusions:

In patients with obstructive APN secondary to urinary calculi, a high CCI score were associated with a higher probability of progression to sepsis. In patients with higher creatinine and higher CCI scores, proactive treatment is usually necessary.

REFERENCES

1.Hsu CY., Fang HC., Chou KJ., Chen CL., Lee PT., Chung HM. The clinical impact of bacteremia in complicated acute pyelonephritis. Am J Med Sci. 2006. 332:175–80.
crossref
2.Bone RC., Balk RA., Cerra FB., Dellinger RP., Fein AM., Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992. 101:1644–55.
3.American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992. 20:864–74.
4.Levy MM., Fink MP., Marshall JC., Abraham E., Angus D., Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003. 29:530–8.
crossref
5.Tambo M., Okegawa T., Shishido T., Higashihara E., Nutahara K. Predictors of septic shock in obstructive acute pyelonephritis. World J Urol. 2014. 32:803–11.
crossref
6.Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med. 2000. 26(Suppl 1):S64–74.
crossref
7.Lim CH., Hwang JS., Kim DJ., Jang SH., Son JH., Cho DS, et al. Risk factors of sepsis in obstructive acute pyelonephritis associated with urinary tract calculi. Urogenit Tract Infect. 2015. 10:108–11.
crossref
8.Amano T., Matsui F., Takashima H., Takemae K. Analysis of patients with septic shock due to urosepsis brought on by ureteral calculi. Hinyokika Kiyo. 2003. 49:1–4.
9.Zahorec R. Ratio of neutrophil to lymphocyte counts—rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001. 102:5–14.
10.Yamanaka T., Matsumoto S., Teramukai S., Ishiwata R., Nagai Y., Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology. 2007. 73:215–20.
crossref
11.Cho H., Hur HW., Kim SW., Kim SH., Kim JH., Kim YT, et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother. 2009. 58:15–23.
crossref
12.Gomez D., Farid S., Malik HZ., Young AL., Toogood GJ., Lodge JP, et al. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg. 2008. 32:1757–62.
crossref
13.Sarraf KM., Belcher E., Raevsky E., Nicholson AG., Goldstraw P., Lim E. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009. 137:425–8.
crossref
14.Yamamoto Y., Fujita K., Nakazawa S., Hayashi T., Tanigawa G., Imamura R, et al. Clinical characteristics and risk factors for septic shock in patients receiving emergency drainage for acute pyelonephritis with upper urinary tract calculi. BMC Urol. 2012. 12:4.
crossref
15.Bossink AW., Groeneveld AB., Koffeman GI., Becker A. Prediction of shock in febrile medical patients with a clinical infection. Crit Care Med. 2001. 29:25–31.
crossref
16.Kamei J., Nishimatsu H., Nakagawa T., Suzuki M., Fujimura T., Fukuhara H, et al. Risk factors for septic shock in acute obstructive pyelonephritis requiring emergency drainage of the upper urinary tract. Int Urol Nephrol. 2014. 46:493–7.
crossref
17.Comarr AE., Kawaichi GK., Bors E. Renal calculosis of patients with traumatic cord lesions. J Urol. 1962. 87:647–56.
18.Angulo JC., Gaspar MJ., Rodríguez N., García-Tello A., Torres G., Núñez C. The value of C-reactive protein determination in patients with renal colic to decide urgent urinary diversion. Urology. 2010. 76:301–6.
crossref
19.Wagenlehner FM., Weidner W., Naber KG. Optimal management of urosepsis from the urological perspective. Int J Antimicrob Agents. 2007. 30:390–7.
crossref
20.Yoshimura K., Utsunomiya N., Ichioka K., Ueda N., Matsui Y., Terai A. Emergency drainage for urosepsis associated with upper urinary tract calculi. J Urol. 2005. 173:458–62.
crossref

Table 1.
Univariable analysis of variables for sepsis between non-sepsis group and sepsis group
Variable Non-sepsis group (n=21) Sepsis group (n=43) p-value
Age (y) 65.43±16.20 61.74±14.67 0.37
Gender     0.51
  Male 5 7  
  Female 16 36  
Performance status     0.98
  0-1 17 36  
  2-4 4 1  
Hospital stay (d) 9.71±8.40 12.53±9.82 0.26
Diabetes mellitus     0.59
  No 12 28  
  Yes 9 15  
HTN/CVD/neurologic disease     0.87
  No 10 25  
  Yes 13 30  
WBC count (×10³/μl) 12.78±7.02 15.05±6.33 0.2
Lymphocyte (%) 11.20±9.44 6.70±4.42 0.011
Lymphocyte count (×10³/μl) 1.18±0.68 0.84±0.40 0.013
Neutrophil (%) 81.43±11.33 88.17±5.38 0.002
Neutrophil count (×10³/μl) 10.69±6.43 13.44±6.01 0.098
PLT count (×10³/μl) 177.19±80.03 184.65±96.16 0.76
PT-INR 1.08±0.20 1.15±0.21 0.16
CRP (mg/L) 106.69±76 207.06±111.66 0.001
Albumin (g/dl) 3.11±0.73 3.00±0.61 0.51
Creatinine (mg/dl) 1.63±1.33 1.96±1.28 0.35
Total bilirubin (mg/dl) 0.87±0.59 1.04±0.38 0.18
Urine culture     0.6
  Negative 11 19  
  Positive 10 24  
Blood culture     0.003
  Negative 18 20  
  Positive 3 23  
Hydronephrosis     0.25
  Grade 1 12 19  
  Grade 2 8 18  
  Grade 3 1 6  
Laterality     0.14
  Right 7 26  
  Left 11 16  
  Bilateral 3 1  
Stone position     0.76
  Upper 14 29  
  Middle 1 5  
  Lower 6 9  
Stone size (mm) 7.52±4.72 8.19±3.85 0.55
  NLR 10.90±8.68 18.67±12.68 0.014
  PLR 199.10±139.26 307.47±345.81 0.17
CCI     0.02
  1-2 15 6  
  3-4 4 11  
  ≥5 2 26  
Observation (n=34) 17 (50.0) 17 (50.0) 0.003
Intervention (n=30) 4 (13.3) 26 (86.7) 0.96
  URS (n=5) 0 (0) 5 (100.0)  
  PCN (n=25) 4 (16.0) 21 (84.0)  

Values are presented as mean±standard deviation, number only, or number (%).

HTN: hypertension, CVD: cardiovascular disease, WBC: white blood cell, PLT: platelet, PT-INR: prothrombin time (seconds)–international normalized ratio, CRP: C-reactive protein, NLR: neutrophil-to-lymphocyte ratio, PLR: platelet-to-lymphocyte ratio, CCI: Charlson comorbidity index, URS: ureterorenoscopy, PCN: percutaneous nephrostomy.

Table 2.
Multivariate analysis of independent variables for sepsis (all patients)
Variable OR 95% CI p-value
Blood culture 8.415 1.660-242.665 0.01
NLR 1.092 1.006-1.142 0.03
CCI score     0.04
  1-2 1 1  
  3-4 1.52 0.678-3.46  
  ≥5 3.70 0.45-30.37  

OR: odds ratio, 95% CI: 95% confidence interval, NLR: neutrophil-to-lymphocyte ratio, CCI: Charlson comorbidity index.

Table 3.
Univariate analysis of variables between the non-emergency drainage group and emergency drainage group within the sepsis group
Variable Non-emergency drainage group (n=17) Emergency drainage group (n=26) p-value
Age (y) 58.00±16.13 64.20±13.39 0.18
Gender     0.9
  Male 3 4  
  Female 14 22  
Performance status     0.69
  0-1 15 21  
  2-4 2 5  
Hospital stay 9.24±10.10 14.70±9.20 0.05
Diabetes mellitus     0.21
  No 13 15  
  Yes 4 11  
HTN/CVD/neurologic disease     0.66
  No 8 0  
  Yes 9 12  
WBC count (×103/l) 15.41±4.63 14.82±7.32 0.77
Lymphocyte (%) 6.41±2.67 6.88±5.28 0.74
Lymphocyte count (×103/l) 0.92±0.31 0.79±0.44 0.29
Neutrophil (%) 87.86±3.62 88.37±6.33 0.77
Neutrophil count (×103/l) 13.58±4.26 13.34±7.01 0.9
PLT count (×103/l) 216.29±100.20 163.96±89.34 0.05
PT-INR 1.13±0.24 1.17±0.18 0.54
CRP (mg/L) 210.26±115.04 204.97±111.64 0.88
Albumin (g/dL) 3.09±0.67 2.93±0.57 0.42
Creatinine (mg/dL) 1.43±0.72 2.30±1.45 0.02
Total bilirubin (mg/dL) 1.01±0.37 1.06±0.39 0.67
Urine culture     0.03
  Negative 11 8  
  Positive 6 18  
Blood culture     0.01
  Negative 12 8  
  Positive 5 18  
Hydronephrosis     0.15
  Grade 1 10 9  
  Grade 2 4 14  
  Grade 3 3 3  
Laterality     0.41
  Right 9 17  
  Left 7 9  
  Bilateral 1 0  
Stone position     0.99
  Upper 12 17  
  Middle 2 3  
  Lower 3 6  
Stone size (mm) 8.76±5.43 7.81±2.38 0.43
  NLR 16.24±8.65 20.27±14.70 0.31
  PLR 278.59±223.01 326.35±410.04 0.66
Septic shock     0.45
  No 15 20  
  Yes 12 6  
CCI     <0.001
  1-2 5 0  
  3-4 9 6  
  ≥5 3 20  

Values are presented as mean±standard deviation or number only.

HTN: hypertension, CVD: cardiovascular disease, WBC: white blood cell, PLT: platelet, PT-INR: prothrombin time (seconds)–international normalized ratio, CRP: C-reactive protein, NLR: neutrophil-to-lymphocyte ratio, PLR: platelet-to-lymphocyte ratio, CCI: Charlson comorbidity index.

Table 4.
Multivariabl group patients le analysis o f independent variabl les in sepsis
Variable OR 95% CI p-value
Creatinine (mg/dl) 5.03 0.82-31.02 0.04
Urine culture 1.092 1.78-350.02 0.01
CCI score     0.05
  1-2 1 1  
  3-4 1.52 1.75-5.609  
  ≥5 3.7 0.169-17.568  

OR: odds ratio, 95% CI: 95% confidence interval, CCI: Charlson comorbidity index.

TOOLS
Similar articles